S A Tech Soft. (SATECH)
TurnaroundScore breakdown: P/E: 1/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹41.5 |
| Market Cap | ₹61.43 Cr |
| P/E Ratio | 27.18 |
| ROCE | 29.91% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -114.19% |
| Debt/Equity | — |
| Sales Growth | -2.75% |
| Promoter Holding | 69.64% |
| 52-Week Range | ₹31.55 — ₹52.7 |
| Sector | IT - Software |
Strengths
- High promoter holding of 69.64% aligns management with minority shareholders.
- Reported ROCE of 29.91% indicates efficient capital deployment, if sustainable.
- Latest quarter revenue of ₹50 crore is significant relative to ₹61 crore market cap, so the business still has an operating base.
- Current price of ₹41.50 is above the 52-week low of ₹31.80, suggesting limited downside from recent lows, though this is not a margin of safety.
Concerns
- Profit growth of -114.19% and latest quarterly net loss of ₹1 crore show deteriorating earnings.
- Piotroski F-Score of 3/9 points to weak financial health and possible operational stress.
- P/E of 27.18 is not meaningful with collapsing profits; no margin of safety.
- No dividend and missing data on book value, ROE, and debt/equity leave critical unknowns.
AI Analysis
Looking at S A Tech Soft, I see a small software consulting company that fails most of my tests. At ₹41.50, the market capitalisation is just ₹61 crore. The 29.91% ROCE initially catches my eye—it suggests that capital was being used efficiently. A 69.64% promoter holding is another positive; owners have skin in the game. But a good business must also earn decent profits consistently, and here the numbers are disturbing. Sales have declined 2.75%, while profit growth has collapsed by 114.19%. The latest quarter shows a net loss of ₹1 crore on sales of ₹50 crore. That is a razor-thin, actually negative, operating result. A P/E of 27.18 is meaningless when earnings are disappearing; Graham would demand a margin of safety, and I see none. The Piotroski F-Score of 3 out of 9 reinforces my caution—this is a weak financial-health signal. There is no dividend, and I cannot even assess book value, ROE, or debt/equity because the data are not available. In the absence of transparency, I cannot classify this as an investment; it is a speculation. The revenue base of ₹50 crore in the latest quarter against a ₹61 crore market cap means the company is not dead, but a low price-to-sales ratio is not enough. I need to see a return to positive net profit, stable sales growth, and evidence that the 29.91% ROCE can be maintained. Until then, this is a 'too hard' pile. If management can turn the business around, there may be value; but I will wait for proof, not hopes.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer